Miochol-e is a drug owned by Bausch And Lomb Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 29, 2019. Details of Miochol-e's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6261546 | Methods and compositions for stabilizing acetylcholine compositions |
Apr, 2019
(5 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Miochol-e is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Miochol-e's family patents as well as insights into ongoing legal events on those patents.
Miochol-e's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Miochol-e's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 29, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Miochol-e Generics:
There are no approved generic versions for Miochol-e as of now.
About Miochol-e
Miochol-E is a drug owned by Bausch And Lomb Inc. It is used for stimulating the parasympathetic nervous system in the treatment of certain medical conditions. Miochol-E uses Acetylcholine Chloride as an active ingredient. Miochol-E was launched by Bausch And Lomb in 1993.
Approval Date:
Miochol-e was approved by FDA for market use on 22 September, 1993.
Active Ingredient:
Miochol-e uses Acetylcholine Chloride as the active ingredient. Check out other Drugs and Companies using Acetylcholine Chloride ingredient
Treatment:
Miochol-e is used for stimulating the parasympathetic nervous system in the treatment of certain medical conditions.
Dosage:
Miochol-e is available in for solution form for ophthalmic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 20MG/VIAL | FOR SOLUTION | Prescription | OPHTHALMIC |